Amprius Technologies (NYSE:AMPX – Free Report) had its price objective raised by B. Riley Financial from $16.00 to $22.00 in a research report sent to investors on Monday,Benzinga reports. They currently have a buy rating on the stock.
Other equities analysts have also issued research reports about the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Craig Hallum upped their price objective on Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a report on Friday. Oppenheimer reiterated an “outperform” rating and set a $17.00 price objective on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Cantor Fitzgerald lifted their target price on Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday. Finally, William Blair reissued an “outperform” rating on shares of Amprius Technologies in a research report on Friday. Eight equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Amprius Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.75.
View Our Latest Stock Report on AMPX
Amprius Technologies Stock Performance
Amprius Technologies (NYSE:AMPX – Get Free Report) last issued its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 25.77%. The firm had revenue of $25.23 million during the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, equities analysts forecast that Amprius Technologies will post -0.45 earnings per share for the current year.
Insiders Place Their Bets
In other news, CTO Constantin Ionel Stefan sold 492,827 shares of the company’s stock in a transaction on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total transaction of $5,933,637.08. Following the completion of the sale, the chief technology officer directly owned 748,696 shares in the company, valued at approximately $9,014,299.84. This represents a 39.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Kang Sun sold 950,548 shares of the stock in a transaction on Friday, January 16th. The stock was sold at an average price of $11.07, for a total value of $10,522,566.36. Following the sale, the director directly owned 1,403,651 shares in the company, valued at approximately $15,538,416.57. This trade represents a 40.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 2,392,269 shares of company stock worth $26,384,359. Corporate insiders own 12.80% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Stephens Investment Management Group LLC acquired a new position in shares of Amprius Technologies during the 3rd quarter worth $11,392,000. Vanguard Group Inc. boosted its stake in Amprius Technologies by 37.0% in the third quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company’s stock valued at $68,513,000 after buying an additional 1,757,395 shares in the last quarter. Baird Financial Group Inc. boosted its stake in Amprius Technologies by 99.9% in the second quarter. Baird Financial Group Inc. now owns 1,000,711 shares of the company’s stock valued at $4,213,000 after buying an additional 500,212 shares in the last quarter. Calamos Advisors LLC bought a new position in Amprius Technologies in the third quarter valued at about $1,799,000. Finally, Jupiter Asset Management Ltd. acquired a new position in Amprius Technologies during the third quarter worth about $2,098,000. Institutional investors and hedge funds own 5.04% of the company’s stock.
Key Amprius Technologies News
Here are the key news stories impacting Amprius Technologies this week:
- Positive Sentiment: Multiple analysts raised ratings and price targets (buy ratings and targets in the low-$20s), signaling more institutional conviction and a higher consensus valuation. Read More.
- Positive Sentiment: MarketBeat highlights record trading volume tied to the Q4 release — volume-backed breakouts increase the odds the rally continues because they show real market conviction. Read More.
- Positive Sentiment: Q4 results showed record revenue growth and the company reported its first positive adjusted quarterly EBITDA; management cited expanding adoption of its 2nd‑gen silicon‑anode batteries and new commercial/defense wins. Read More.
- Positive Sentiment: IBD upgraded AMPX, adding a reputable media/ratings endorsement that can attract momentum investors and retail flows. Read More.
- Neutral Sentiment: Analyst fair‑value estimates have moved higher (consensus and some firms into the ~$20–22 range), but coverage remains relatively light — helpful for upside if coverage expands, yet still leaves forecasts dispersed. Read More.
- Negative Sentiment: Despite progress, Amprius remains unprofitable on a GAAP basis and guidance/consensus EPS still negative for the year; valuation and momentum make the stock volatile (high beta), so downside risk exists if growth or NDAA/compliance milestones slip. Read More.
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
See Also
- Five stocks we like better than Amprius Technologies
- Buy this Gold Stock Before May 15th, 2026
- America’s 1776 happening again
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
- My Epstein Story
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
